• A neurotoxic syndrome called Intermediate syndrome has been

  2019-10-11

  

  A neurotoxic syndrome called “Intermediate syndrome” has been described after acute cholinergic crisis, which has been interpreted as the result of pre- and postsynaptic disruptions of neuromuscular transmission (Senanayake and Karalliedde, 1987). Other toxic effects with unknown molecular targets h

• br Introduction Fibroblast growth factors FGF are a

  2019-10-11

  

  Introduction Fibroblast growth factors (FGF) are a family of 18 secreted ligands that bind to four receptor tyrosine kinase (RTK) FGF receptors (FGFR1–4). The interaction of FGFs with their cognate receptors results in the activation of a number of downstream signaling pathways, including the MAP

• The imaging and biochemical data presented

  2019-10-11

  

  The imaging and biochemical data presented here demonstrated that in T cells, AEP played a specific function in cleaving Foxp3 but not Tbet. These results are in accordance with previous AEP studies where it has been shown that AEP substrates in part are not amenable to other protease activity. In a

• The EGFR belongs to the ErbB family of receptor tyrosine

  2019-10-11

  

  The EGFR belongs to the ErbB family of receptor tyrosine kinases (RTKs), comprised of four members: EGFR (ErbB1, HER1), HER2 (ErbB2), HER3 (ErbB3) and HER4 (ErbB4) [24]. HER receptors are activated by a group of epidermal growth factor (EGF) ligands and undergo homo- or hetero-dimerization during th

• As an endogenous negative modulator CRBN inhibits AMPK

  2019-10-11

  

  As an endogenous negative modulator, CRBN inhibits AMPK’s activation (phosphorylation of Thr172) by directly binding to the α-subunit of AMPK, disrupting γ-subunit recruitment to the AMPK complex (Lee et al., 2011, Lee et al., 2013). In our study, we did not focus on AMPK activation, since only a si

• Based on the SUMO SIM interaction involved in SUMOD position

  2019-10-11

  

  Based on the SUMO–SIM interaction involved in SUMOD positioning, a SUMO2ΔSBD (SIM-binding domain; Q30A, F31A, I33A) mutant can be investigated that disrupts this important binding interface (Eisenhardt et al., 2015; Meulmeester, Kunze, Hsiao, Urlaub, & Melchior, 2008). In Fig. 4A, multiturnover assa

• br Conclusions br ISG is an ubiquitin like protein

  2019-10-11

  

  Conclusions ISG15 is an ubiquitin‐like protein that is induced by treating mammalian MK-4827 with interferon‐α/β. UbE1L was identified as the E1‐activating enzyme for ISG15 in the course of experiments that demonstrated that the nonstructural or NS1 protein of influenza B virus inhibits ISG15

• In the present study synthesis of Bi MoO nanoplates

  2019-10-11

  

  In the present study, synthesis of Bi2MoO6 nanoplates via DNA-templated hydrothermal method has been undertaken. The synthesis was done through the hydrothermal method by means of the reaction of bismuth nitrate pentahydrate (Bi(NO3)3·5H2O) with sodium molybdate dihydrate (Na2MoO4·2H2O) precursor in

• Previous studies showed that many steroidogenic enzymes

  2019-10-11

  

  Previous studies showed that many steroidogenic enzymes act when the enzyme binds to the cofactor first [30]. In the present study, we showed that HPTE inhibited both AKR1C14 and RDH2 in a mixed mode when cofactor was used. This indicates that HPTE interferes with cofactor-binding residues although

• br Materials and methods br Acknowledgments

  2019-10-11

  

  Materials and methods Acknowledgments Introduction Proton pumps convert the energy of high-energy compounds into the Sanguinarine chloride of protons across biomembranes. They play two physiological roles: pH regulation and the formation of proton-motive forces in their membranes. The simpl

• br Role of cysLT signaling on various neurological complicat

  2019-10-11

  

  Role of cysLT signaling on various neurological complications which are associated with Alzheimer’s disease Alzheimer’s disease, first described in 1906 by Alois Alzheimer, is a neurodegenerative disease and a very common cause of dementia progressively leading to death. Even though years of rese

• We have previously disclosed the discovery of

  2019-10-11

  

  We have previously disclosed the discovery of a 7-azaindole-3-acetic beta adrenergic receptors CRTh2 antagonist chemotype 1 from HTS and its subsequent optimization to give 2 as a potent and orally bioavailable inhibitor of eosinophil shape change (SC) in human whole blood. Subsequent to disclosure

• br Conclusions br Statement of authorship

  2019-10-11

  

  Conclusions Statement of authorship Nonaneurysmal subarachnoid hemorrhage (NA-SAH) differs from aneurysmal subarachnoid hemorrhage (SAH) in both clinical course and outcome. In spite of many reports and case series since the first description in 1985, the etiology of NA-SAH remains uncertain

• In normal cells the apoptotic stimuli lower

  2019-10-10

  

  In normal cells, the apoptotic stimuli lower the expression level of antiapoptotic proteins by increasing turnover rate and preventing the constant degradation of proapoptotic proteins. Thus, the dysregulation of anti-/pro-apoptotic proteins will confer the survival of cancer PPM-18 via enhancing t

• Herein the interactions of etamicastat nepicastat

  2019-10-10

  

  Herein, the interactions of etamicastat, nepicastat and zamicastat with P-gp and BCRP were evaluated. Although recent investigations have been performed to assess the involvement of P-gp in the terbinafine hydrochloride exposure of nepicastat and etamicastat (Loureiro et al., 2015), the contributio

16520 records 981/1102 page Previous Next First page 上5页 981982983984985 下5页 Last page